<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF46D1B5-9EE9-459F-8D6D-68C3987370BD"><gtr:id>EF46D1B5-9EE9-459F-8D6D-68C3987370BD</gtr:id><gtr:name>University Hospitals of Leicester NHS</gtr:name><gtr:address><gtr:line1>Leicester Royal Infirmary</gtr:line1><gtr:line2>Infirmary Square</gtr:line2><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 5WW</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37B04F53-AFDA-41A8-8216-1EEE7410C7DC"><gtr:id>37B04F53-AFDA-41A8-8216-1EEE7410C7DC</gtr:id><gtr:name>Leicester Royal Infirmary</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF46D1B5-9EE9-459F-8D6D-68C3987370BD"><gtr:id>EF46D1B5-9EE9-459F-8D6D-68C3987370BD</gtr:id><gtr:name>University Hospitals of Leicester NHS</gtr:name><gtr:address><gtr:line1>Leicester Royal Infirmary</gtr:line1><gtr:line2>Infirmary Square</gtr:line2><gtr:line4>Leicester</gtr:line4><gtr:postCode>LE1 5WW</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37B04F53-AFDA-41A8-8216-1EEE7410C7DC"><gtr:id>37B04F53-AFDA-41A8-8216-1EEE7410C7DC</gtr:id><gtr:name>Leicester Royal Infirmary</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/64CBEC34-1F44-42EB-A6F5-3F0A724BEDDA"><gtr:id>64CBEC34-1F44-42EB-A6F5-3F0A724BEDDA</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Steward</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_G0802524"><gtr:id>634E49EB-9282-4940-B7DD-797117A17166</gtr:id><gtr:title>Support for a FACS Cell Sorter at the University of Leicester</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_G0802524</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>The University of Leicester was awarded &amp;pound;536K for a FACS cell sorter. There is a major and urgent need across researchers in Medical and Biological Sciences and the MRC Toxicology Unit at Leicester for this equipment, which can be used to physically isolate specific cell types from heterogenous cell populations in translational projects. The availability of a new system is crucial to the success of several areas of translational research, most notably the development of stem cell technology. In addition, as a core facility it will significantly enhance the output of a number of ongoing research projects.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>536000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cancer Studies</gtr:department><gtr:description>Apoptosis and cell cycle analysis after UVA,UVB induced cytotoxicity by selected drugs of Hut78 human T-cell lymphoma</gtr:description><gtr:id>8C7895A5-C5AE-48CC-A8DC-C122D6893D90</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>Hpc1jhLsqbZ-1</gtr:outcomeId><gtr:partnerContribution>design of study</gtr:partnerContribution><gtr:piContribution>advice on use of FACS and technical supervsion fo research</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cardiovascular Sciences</gtr:department><gtr:description>Characterization of mesenchymal stem cells isolated from umbilical cord</gtr:description><gtr:id>5B559A7A-19D6-4623-B148-4D50B7B8C23E</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>DHbjrh3tvqX-1</gtr:outcomeId><gtr:partnerContribution>lead in design of research</gtr:partnerContribution><gtr:piContribution>contribution to research plan and running of FACS sorter</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Determine mechanism of decrease in smooth muscle actin in fibrocytes when cocultured with ASM</gtr:description><gtr:id>471AD5F7-C726-4632-883F-62DC80CB6527</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>oYFbLCz5LYU-1</gtr:outcomeId><gtr:partnerContribution>design of projest and colelction fo samples</gtr:partnerContribution><gtr:piContribution>input to design of research project and running of FACS sorter</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leicester General Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Surgery and Pathology</gtr:department><gtr:description>Blood analysis of fish oil treated patients with pancreatic cancer</gtr:description><gtr:id>BB1DBFF9-FA27-4234-8295-22193C3DDDD4</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>eMJ1sFoyLC5-1</gtr:outcomeId><gtr:partnerContribution>Joint protocol writing and patient recruitmetn</gtr:partnerContribution><gtr:piContribution>joint writing of prject protocol and supervision of FACS sorting. Patient recruitemnt</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leicester Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Anaesthetics</gtr:department><gtr:description>Sorting leucocyte rich plasma for nociceptin receptor for mRNA analysis</gtr:description><gtr:id>01FC6ACD-139C-4C82-B81F-DD51C37D6351</gtr:id><gtr:impact>Presentation at meeting and published abstract: Use of preparative fluorescence-activated cell sorting (FACS) to profile opioid receptor and peptide mRNA expression on human granulocytes, lymphocytes, and monocytes. Annual Meeting of the Anaesthetic-Research-Society Location: Univ Nottingham, Nottingham, ENGLAND: JUL 01-02, 2010 
BRITISH JOURNAL OF ANAESTHESIA Volume: 105 Issue: 5 Pages: 707-708 Published: NOV 2010
This was multidisciplinary research with Anaesthetic department.</gtr:impact><gtr:outcomeId>NKJxytBVv4Q-1</gtr:outcomeId><gtr:partnerContribution>Will lead to joint publications and potential for joint grant application</gtr:partnerContribution><gtr:piContribution>Advice and support throughout learning period of using Cell sorter. Contribution of technical support.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Potential of Repurposed Drugs in Preventing Malignant Pleural Mesothelioma.</gtr:description><gtr:id>A80C4839-9D38-4C8C-AEB8-4C665758A13D</gtr:id><gtr:impact>Oral and poster conference presentations.</gtr:impact><gtr:outcomeId>58c9424e2a2e78.00682812-1</gtr:outcomeId><gtr:partnerContribution>Provision of a library of repurposed drugs and associated data.</gtr:partnerContribution><gtr:piContribution>Conceived the idea and designed the project. Conducted the work and interpreted data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leicester Royal Infirmary</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Surgery</gtr:department><gtr:description>Analysing t-cell populations from patient blood after fish oil application on patients with pancreatitis</gtr:description><gtr:id>254DC3CC-854D-4993-895A-6587D8BB285A</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>b35iUT8Uq4s-1</gtr:outcomeId><gtr:partnerContribution>Design of clincal trial and patient enrollment. Contribution of time of research fellow to FACS analysis</gtr:partnerContribution><gtr:piContribution>Collaborating in clincal trial and providing expertise and infrastructure in laboratory with FACS machine</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cardiovascular Sciences</gtr:department><gtr:description>Directed evolution and structure/function analysis of proteins displayed on cell surface of B cells, DT40 and HEK293 cells</gtr:description><gtr:id>C420A537-75D2-409C-9123-C462C419CD6E</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:outcomeId>EXt2ijHmL5b-1</gtr:outcomeId><gtr:partnerContribution>Stduy design and provision of specimens</gtr:partnerContribution><gtr:piContribution>Supervision of experiments using FACS sorter</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Genetics</gtr:department><gtr:description>Identification of specific cells types from lung that express KRAS-G12D by nasal Cre delivery.</gtr:description><gtr:id>7BAFF5DC-E5FA-4117-B24C-24FB973D397E</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58c93f68159a92.03876891-1</gtr:outcomeId><gtr:partnerContribution>Design of the study, generating the samples, performing experiments and interpreting data.</gtr:partnerContribution><gtr:piContribution>Help with the isolation by FACS sorting of specific cell populations, through assistance with the experimental design and running of the instrument.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Identifying which cellular subtype is responsible for producing elevated concentrations of IFNalpha in PBMCs from COPD patients compared to controls</gtr:description><gtr:id>DE9C53CC-E185-4C81-98FF-2C321C1AD763</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>ochwuG75YkW-1</gtr:outcomeId><gtr:partnerContribution>Primary designers of research project and collection of samples</gtr:partnerContribution><gtr:piContribution>Study design and running of FACS sorter</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cardiovascular Sciences</gtr:department><gtr:description>Developing Ang2 ligand trap by using Tie2 ectodomain mutants expressed in transfected DT40 cells. Sorting of mutants</gtr:description><gtr:id>6DCC7550-E36F-42C6-A36B-FFF2A8D12042</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>s37mB4JeHk4-1</gtr:outcomeId><gtr:partnerContribution>Design of study and sample provision</gtr:partnerContribution><gtr:piContribution>Practical support for us of FACS machine</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leicester General Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Surgery and Pathology</gtr:department><gtr:description>Sorting cancer stem cells from pancreatic tumors</gtr:description><gtr:id>9BE0E352-8895-4049-8408-F619125A3A1B</gtr:id><gtr:impact>Is being used to rpedict response to therapy of pancreas cancer. Multidisciplinary with Pathology Department</gtr:impact><gtr:outcomeId>HDdGeRuLmKi-1</gtr:outcomeId><gtr:partnerContribution>Has extended models of use of stem cell sorting to pancreas</gtr:partnerContribution><gtr:piContribution>Support to train in use of FACS sorter and advice on optimal sorting techniques</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Sorting to establish the stable transfection of clones</gtr:description><gtr:id>DEEACFAE-4461-485B-BB28-A8551E7A948C</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58c940124fd5d8.76558245-1</gtr:outcomeId><gtr:partnerContribution>Study design, generation of samples and interpretation of data</gtr:partnerContribution><gtr:piContribution>Support with experimental design and running the FACS sorter.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cancer Studies</gtr:department><gtr:description>Apoptosis and cell cycle analysis of human melanoma and lymphoma</gtr:description><gtr:id>5185A961-7791-4050-B2B5-F9BA55AC903D</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>dkb6msWANhG-1</gtr:outcomeId><gtr:partnerContribution>Design of project</gtr:partnerContribution><gtr:piContribution>advice on use of FACS in programme and supervision of running of FACS sorting</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Geology</gtr:department><gtr:description>Assessing expression levels of C1GaIT1, and its chaperone protein, IgA and non-IgA in B cells</gtr:description><gtr:id>698CDEA8-105A-41FF-A056-9E4248D1E4E6</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58c940f11cab47.22818434-1</gtr:outcomeId><gtr:partnerContribution>Study design, generation of samples and interpretation of data</gtr:partnerContribution><gtr:piContribution>Support with experimental design and running the FACS sorter.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cancer Studies</gtr:department><gtr:description>Apoptosis and cell cycle analysis after UVA,UVB treatment of skin cells</gtr:description><gtr:id>5FC8DBB2-021B-41AA-A496-3D764421C023</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>Nz2AG6R2Rdq-1</gtr:outcomeId><gtr:partnerContribution>design of project</gtr:partnerContribution><gtr:piContribution>support for use of FACS and guidance on appropriate use</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Leicester Medical School</gtr:department><gtr:description>Expression And Functional Significance Of The Endocannabinoid System In Human Spermatozoa</gtr:description><gtr:id>DB966A05-7696-4A1D-8F51-9E58D3689BC0</gtr:id><gtr:impact>Has already led to presentation and abstract publication: &amp;quot;Expression And Functional Significance Of The Endocannabinoid System In Human Spermatozoa&amp;quot; FERTILITY AND STERILITY: Volume: 96 Issue: 3 Supplement: 1 Pages: S87-S87 Published: SEP 2011
This is multidisciplinary between Reproductive Sciences and Oncology and is to be extended to other istitutions in UK and abroad.</gtr:impact><gtr:outcomeId>JSzLLStUuNf-1</gtr:outcomeId><gtr:partnerContribution>Has establsihed use of stem cell biology in endocannabinoid research and potential use in infertility</gtr:partnerContribution><gtr:piContribution>support to research group in use of FACS sorter and advice on optimal separation of stem cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Sorting airway epithelial stem cells from foetal human lung tissue stained with Hoechst 3342</gtr:description><gtr:id>FF4773D1-97BC-4EB5-B570-3E532C6BB7F9</gtr:id><gtr:impact>Too early</gtr:impact><gtr:outcomeId>ckYg9tV86yB-1</gtr:outcomeId><gtr:partnerContribution>lead in designing ersearch prokject and collection specimens</gtr:partnerContribution><gtr:piContribution>use of FACS sorter and advice on protocol design</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Local cancer fundraising group - Hope Leicester</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BC0D6D2C-15DC-444C-8C1D-11EAF6D1E746</gtr:id><gtr:impact>Presentation to 60-80 attendees on use of stem cells in research and cancer prevention research. Many questions and extensive discussion.

Invited back for next year as felt to be of great interest</gtr:impact><gtr:outcomeId>Mw93jgc56vp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B483A43A-DD43-4BC6-B9B8-2E09A0D0AA44</gtr:id><gtr:impact>40 pupils attnded each event as part of University outreach intiative funded as part of GENIE programme. Talk on research in cacner prevention and role of stem cells in research. Many questions and considerable interest.

High interest reported by school and organsiers fo events.</gtr:impact><gtr:outcomeId>seQL4rFaZg4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science evening at Lutterworth High School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5E1D2BC0-62CB-499F-9DFB-4453635537E7</gtr:id><gtr:impact>50 schoolchildren and parents attended and sparked considerabel interest among both groups with questions and discussion

Very well received by college staff who made the invitation</gtr:impact><gtr:outcomeId>Kzv3yGL7bUL</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CRUK fundraisers annual meeting Leicester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>057D154B-0354-4DBE-AC3B-C53D55662F24</gtr:id><gtr:impact>75 attendees at this talk on research in unit and large number of questions and discussion

Visits to laboratories provided subsequently and requests for more talks.</gtr:impact><gtr:outcomeId>U7YKmmTRCsP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>13175</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Training &amp;amp; Career Development Board - Research Bursary</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>DA04DE61-A958-429F-B13A-905C4BC2CC93</gtr:id><gtr:outcomeId>56e0a2b665c3d2.79418518</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Experimental Cancer Medicine Centre Programme</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>B0BFD587-810E-4EB8-83F2-5AC0B712CDAD</gtr:id><gtr:outcomeId>sUnyu9BPrzz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme grant</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>76C4147D-17FD-4FD0-920B-803E8D3B5741</gtr:id><gtr:outcomeId>ULuJGSRu4jQ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>218798</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2015-07-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>23AE7A68-EBB0-410C-AC3A-8AD40F7DDCDC</gtr:id><gtr:outcomeId>546d108aaafdb1.03641488</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>133500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical PhD fellowship</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Hope Against Cancer (Rutland and Leicestershire)</gtr:fundingOrg><gtr:id>9F8DC173-554A-4DDB-9D07-7D304F3E5200</gtr:id><gtr:outcomeId>56e0a7680b9506.27521750</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99245</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>B8C2362E-F7CE-4513-AE9F-72FD3B9DB76C</gtr:id><gtr:outcomeId>58c943fe8f41a6.61457533</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR project grant scheme</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>1BCEEDC4-5D65-4E49-9214-C78AEA79819B</gtr:id><gtr:outcomeId>R1wgUB8f3wz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Experimental Cancer Medicine Centre</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:fundingRef>C10604/A25151</gtr:fundingRef><gtr:id>27EDCC03-E219-4069-A7C7-FA65DFF60C93</gtr:id><gtr:outcomeId>58c943877648d1.18925727</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>212CDBEB-8ED5-4037-B4E6-3082FBEBBD54</gtr:id><gtr:title>In&amp;nbsp;vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer.</gtr:title><gtr:parentPublicationTitle>Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f8e083fa29525075a8abebe44964f9a"><gtr:id>3f8e083fa29525075a8abebe44964f9a</gtr:id><gtr:otherNames>N??ez-S?nchez M?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0278-6915</gtr:issn><gtr:outcomeId>58c93a934ce5c3.72146546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1A10B19-142B-4043-B59D-87CD447364BE</gtr:id><gtr:title>Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33afc52beae746b1636cabbfc5f4448b"><gtr:id>33afc52beae746b1636cabbfc5f4448b</gtr:id><gtr:otherNames>Howells LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>abhKCHCp6Lt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39027053-4A4D-43E4-A947-8DCD212B4199</gtr:id><gtr:title>Curcumin: the potential for efficacy in gastrointestinal diseases.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51caa7ca1d2c460382ddd722eed6a312"><gtr:id>51caa7ca1d2c460382ddd722eed6a312</gtr:id><gtr:otherNames>Irving GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1521-6918</gtr:issn><gtr:outcomeId>pm_53cd4b2d4b2147628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F7A4821-985C-4DE5-9A45-5DFDB4E6C53E</gtr:id><gtr:title>Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86bea5c04d55a7bddf9ac224366bcf3d"><gtr:id>86bea5c04d55a7bddf9ac224366bcf3d</gtr:id><gtr:otherNames>James MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56bdfd087187e9.58302562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACD70E67-153B-44B7-BBF0-6F7EADF3FEB4</gtr:id><gtr:title>Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96af351589f87a92b5f680c20d236494"><gtr:id>96af351589f87a92b5f680c20d236494</gtr:id><gtr:otherNames>Wright AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>58c93beda964b6.58372370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F59C928-BE8B-4B23-8AB1-88791AA9F919</gtr:id><gtr:title>Inhibition of prostate cancer cell growth by 3',4',5'-trimethoxyflavonol (TMFol).</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c7b3699cdb380c861c4c98c042c082a"><gtr:id>4c7b3699cdb380c861c4c98c042c082a</gtr:id><gtr:otherNames>Hill CU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>56bdfd08a01770.89101804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D3DCFE-9A80-4490-B92D-2479FC98CB8B</gtr:id><gtr:title>Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem?.</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff96a4619db26b68193745fabc65031d"><gtr:id>ff96a4619db26b68193745fabc65031d</gtr:id><gtr:otherNames>Haqq J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>56e0a003da0a39.49867153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>301F88E5-3E1D-4278-BD7D-6FCD0B34041D</gtr:id><gtr:title>Novel analogues of resveratrol: metabolism and inhibition of colon cancer cell proliferation</gtr:title><gtr:parentPublicationTitle>Tetrahedron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77a6db165ec09f529bac7a7976a443a0"><gtr:id>77a6db165ec09f529bac7a7976a443a0</gtr:id><gtr:otherNames>Simon C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53cd4bd4b1bea74e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE2B9C36-A91A-4863-AE71-B7BBFF40E909</gtr:id><gtr:title>Dietary intake of rosmarinic acid by Apc(Min) mice, a model of colorectal carcinogenesis: levels of parent agent in the target tissue and effect on adenoma development.</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80aafaf2d275cb463fbc5c6028ba63ce"><gtr:id>80aafaf2d275cb463fbc5c6028ba63ce</gtr:id><gtr:otherNames>Karmokar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>pm_53cd4b1d4b1f1b194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF183CC4-92B8-453B-AF99-326B40135D5B</gtr:id><gtr:title>Toll-like receptor 9 dependent interferon-a release is impaired in severe asthma but is not associated with exacerbation frequency.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96af351589f87a92b5f680c20d236494"><gtr:id>96af351589f87a92b5f680c20d236494</gtr:id><gtr:otherNames>Wright AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>56e0a003b437a6.97732176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91929995-3895-4BC0-8D2A-0D9F80FC63F7</gtr:id><gtr:title>Effects of a Grapevine Shoot Extract Containing Resveratrol and Resveratrol Oligomers on Intestinal Adenoma Development in Mice: In Vitro and In Vivo Studies.</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59392b67982b338a7ed73de91d1f2fde"><gtr:id>59392b67982b338a7ed73de91d1f2fde</gtr:id><gtr:otherNames>Empl MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>5aa842945da327.55916529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC201BDE-C3F0-4BFC-A0D8-4F07418CDF5A</gtr:id><gtr:title>Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/964e0d751a67a75fd9320692106246b0"><gtr:id>964e0d751a67a75fd9320692106246b0</gtr:id><gtr:otherNames>Patel KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>doi_53cd4bd4b1d9e197</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_G0802524</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>986F1CAE-CC43-4D59-8F85-A91971E4C4BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Other</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>